UMEDIC GROUP BERHAD

KLSE (MYR): UMC (0256)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.60

Today's Change

0.00 (0.00%)

Day's Change

0.595 - 0.60

Trading Volume

33,300

Financial
Market Cap

Market Cap

224 Million

NOSH

374 Million

Latest Quarter

Latest Quarter

31-Jul-2024 [#4]

Announcement Date

04-Sep-2024

Next Quarter

31-Oct-2024

Est. Ann. Date

04-Dec-2024

Est. Ann. Due Date

30-Dec-2024

QoQ | YoY

91.72% | -9.97%

T4Q Result

Revenue | NP to SH

54,570.000 | 8,987.000

RPS | P/RPS

14.59 Cent | 4.11

EPS | P/E | EY

2.40 Cent | 24.96 | 4.01%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.19 | 3.12

QoQ | YoY

-3.6% | -12.88%

NP Margin | ROE

17.03% | 12.49%

F.Y. | Ann. Date

31-Jul-2024 | 04-Sep-2024

Latest Audited Result

Latest Audited Result

31-Jul-2023

Announcement Date

03-Nov-2023

Next Audited Result

31-Jul-2024

Est. Ann. Date

03-Nov-2024

Est. Ann. Due Date

27-Jan-2025

Annual (Unaudited)

Revenue | NP to SH

54,570.000 | 8,987.000

RPS | P/RPS

14.59 Cent | 4.11

EPS | P/E | EY

2.40 Cent | 24.96 | 4.01%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.19 | 3.12

YoY

-12.88%

NP Margin | ROE

17.03% | 12.49%

F.Y. | Ann. Date

31-Jul-2024 | 04-Sep-2024

Annualized Result

Revenue | NP to SH

54,570.000 | 8,987.000

RPS | P/RPS

14.59 Cent | 4.11

EPS | P/E | EY

2.40 Cent | 24.96 | 4.01%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

13.24% | -12.88%

NP Margin | ROE

17.03% | 12.49%

F.Y. | Ann. Date

31-Jul-2024 | 04-Sep-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted EPS Growth 1 / 4 25.00% 1 / 8 12.50%
Total Dividend Years 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 3.28% 3.81%
Average Net Profit Margin 16.88% 19.77%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 4 25.00%
Total Positive Profit Years 4 / 4 100.00% 4 / 4 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 4 / 4 100.00%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 4 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 4 0.00%
Total Dividend Years 0 / 4 0.00% 0 / 4 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 4 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 4 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 4 0.00%
Average ROE 18.34% 18.34%
Average Net Profit Margin 16.86% 16.86%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 54,570 54,570 54,570 46,214 46,214
NP to SH 8,987 8,987 8,987 7,704 7,704
Dividend 0 0 0 0 0
Adjusted EPS 2.40 2.40 2.40 2.06 2.06
Adjusted DPS 0.00 0.00 0.00 0.00 0.00

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 27.25% 23.81% 20.11% 9.04% 19.01%
NP to Owner 91.72% -9.97% -12.88% 35.08% 25.78%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 92.86% -10.00% -13.04% 35.00% 25.58%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 0.00% 18.08% 18.08% 0.00% 18.08% 18.08% 20.11% 18.08% 18.08%
NP to Owner 0.00% 16.65% 16.65% 0.00% 16.65% 16.65% -12.88% 16.65% 16.65%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 0.00% 16.50% 16.50% 0.00% 16.50% 16.50% -13.04% 16.50% 16.50%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
Be the first to like this. Showing 50 of 196 comments

faralenz77

Sold all. Director continue selling.

2023-08-02 10:14

4dking777

Power off

2023-08-09 15:47

Ramesh88

looks like going to take off soon ....

2023-09-05 15:53

Ramesh88

Anytime soon...

2023-09-06 12:13

roger3210

Quarter result to be announced very soon. be cautious

2023-09-06 12:37

Ramesh88

Results out already...

2023-09-12 13:57

amateurJR

Next year fengshui theme will benefit this company

2023-09-15 09:50

eugenewong794

Late QR? hopefully a surprise good result, the ceo is optimistic about the company, but as they have foreign cilents, profits made in FX should increase as MYR is depreciating

2024-03-10 12:14

Rose001

Post removed.Why?

2024-03-10 22:40

Rose001

its quarterly result is out, not so good

2024-03-11 14:23

eugenewong794

Share price likely bearish in short term, but prospects still good and transer to main market is progressing well, they are nett cash position and little debt

2024-03-11 14:29

Cptzer0

result is acceptable, price didn't drop much also

2024-03-11 17:41

Remnant17

High chance this will RISE from today.

KUALA LUMPUR (March 12): Phillip Capital has maintained its “buy” rating on UMediC Group Bhd at 66 sen with a higher target price (TP) of RM1.08 (from 87 sen) and said UMediC’s 6MFY24 core net profit of RM5.3 million (+7.8% y-o-y) was in line with house forecast but missed consensus estimates.
In a note on Tuesday, the research house said the sequential earnings improvement was mainly driven by better margins from the manufacturing and distribution segments.
“We raise our target price to RM1.08 (from 87 sen) after rolling forward our valuation horizon to FY25, based on unchanged 25x PE multiple.

“We expect the commencement of new factory and product launches to drive stronger earnings delivery ahead.
“Key risks include slowdown in medical equipment demand, and the loss of license,” it said.

2024-03-12 08:52

Remnant17

Can collect

2024-03-15 08:54

Ramesh88

What happened to this stock...Every week only selling and there is no buying....

2024-03-18 11:03

Remnant17

Just collect, cheap

2024-03-20 11:16

Cptzer0

buy when go lower...

2024-03-20 16:14

Remnant17

(UMC) transition to the main market is progressing well on track, according to executive director/chief executive officer Lim Taw Seong.

“We believe that this strategical move is poised to unlock vast new opportunities for us to further growth and expand which underscores our continuous commitment in bringing excellence towards healthcare catering to the evolving needs of the industry,” Lim said in a statement.


“As we continue to expand, we have also started to ramp up our efforts by strengthening our workforce in anticipation of the imminent launch of our new facility slated to commence production in the coming months.

“The new factory will not only double our manufacturing capabilities but also enable us to meet the rising demand for medical consumables globally enabling us to better grow our regional footprint and propel us to new heights,” he added.

2024-03-21 14:25

Remnant17

Added like crazy, no sweat man. So cheap...keep for children or charity . Cheers and all the best to diamond hands holders!

2024-03-29 16:20

Remnant17

Already double check with consultants, its just being cool and not be swayed by nay sayers .. so be rest assured diamond hands holders!

2024-03-29 16:21

silentWolf

T-price 0.64 , high price 0.66

2024-04-04 09:04

Cptzer0

keep monitor....

2024-04-05 15:26

vijay99

when the transfer to main market will happen ? i think easily can reach RM1 in weeks

2024-04-23 17:00

vijay99

annoucement dated 18th April meaning its thursday....2 market days means friday and monday , so tuesday should have been transferred , but today wednesday meaning 4th day already...maybe need to wait further annoucements.

2024-04-24 10:25

vijay99

its 2 market days upon annoucement on the transfer date to Bursa...so i think Umedic need to inform the intended transfer date to Bursa first...and after that , 2 days from the date Umedic inform Bursa kot

2024-04-24 12:12

Cptzer0

Congrats, transfering to main board on 29 april, not march la

2024-04-25 17:46

Flykite

Cannot move. Not much volume. Not eager to push up.

2024-05-09 17:17

Ramesh88

start moving and hope all the way .....

2024-05-14 11:38

Ramesh88

Needs more power to next level....

2024-05-14 15:05

eugenewong794

At this valuation, the company needs to prove its able to grow at a double digit CAGR in order to justify it, if they cant the share price will fall off a cliff and they might not deserve such a high valuation

2024-05-14 18:13

Ramesh88

HLIB raised the target price and advising to accumulate this stock .

2024-05-14 21:50

legendmonkey

UMC might benefit from the tariff impose by USA on China. Buy before it surge !

2024-05-15 14:59

Rose001

Post removed.Why?

2024-05-16 12:07

Rose001

@whkwoon yes but only members can get to watch it :(

2024-05-17 10:49

Ramesh88

I think results coming out below expectation ....

2024-06-06 15:51

Ramesh88

Yes agreed ... HLIB

2024-06-06 16:46

Michael Kwok

Sell call umc 69.5
Tp 50 cents range a while then see.
6/6/24 7.44pm

2024-06-06 19:43

Ramesh88

🤣

2024-06-14 14:42

Ramesh88

No words and hope for this counter...

2024-06-14 16:08

Ramesh88

What happened to this stock and HLIB is still recommending to buy and accumulate ...

2024-06-26 10:51

Waller

Revenue declined slightly only. It's still more than Rm10 mil

2024-07-22 12:17

fruitcake

hlib buy = sell. same for focusp, mnhldg. i said umc heading southbound many weeks ago

2024-07-29 16:57

DividendGuy67

Fwiw, 25 days ago, I published an article showing where I thought was the Accumulation Zone, which was what I had drawn - I thought it could be within 0.62-0.63. So, I queued to buy at 0.63 and today, my trade was executed. Today's low is 0.625. My position size is small, less than 1% capital, as I consider this a C-grade trade. Nevertheless, good to have skin in the game.

Just curious, did anyone else saw my article and took action?

2024-07-29 19:12

DividendGuy67

I note today's range is reasonably wide - 0.625 to 0.655. Price range like this is likely to fool a lot of day traders, or those watching price ticks whilst market is trading. Many times in my past life, I watched price tickers during the day, and got fooled to change my orders to chase. However, nowadays, I just leave it and don't watch price ticks. More often than not, when we don't chase, when we don't care what the outcome of the trade will be, we get better fills, better trading results, better outcome to the growth of our accounts.

2024-07-29 19:15

DividendGuy67

For this type of chart, precision matters. I can still be wrong. Price is still downtrending. If it breaks support, then, nothing to do, until price stabilizes. Now, I just follow my plan and queue to sell at what I think will be the Selling Zone and ignore everything else. Plan the trade and trade the plan. Everything else is noise.

2024-07-29 19:16

Ramesh88

No rebound yet, any hope for this stock since HLIB is promoting to accumulate this stock to their customers.....

2024-08-07 11:13

Waller

I guess it will shoot up when it transfers to main board ..

2024-08-09 20:02

Noobinvestor99

Any new TP on this stock?

2 months ago

Post a Comment